Persistent URL of this record https://hdl.handle.net/1887/104598
In Collections
This item can be found in the following collections:
![Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials
- All authors
- Nout, R.A.; Peters, E.E.M.; Jurgenlienik-Schulz, I.M.; Jobsen, J.J.; Mens, J.W.M.; Stelloo, E.; Smit, V.T.H.; Bosse, T.; Creutzberg, C.L.
- Date
- 2014-09-01
- Volume
- 90
- Pages
- S110 - S111